International ERDERA funding awarded for novel autism treatment research. Read more
« Les lieux riment avec dépression » : des voix s’élèvent pour dénoncer la vétusté de l’hôpital Douglas. Lire ici
*/ We are pleased to announce that Dr. Richard Montoro has been appointed Psychiatrist-in-Chief at the McGill University Health Centre (MUHC) and Medical Co-Lead of the MUHC Mental Health Mission, effective January 1, 2026.
Dr. Montoro brings extensive clinical expertise, a strong academic background, and proven leadership experience that will be invaluable in advancing the Mental Health Mission and guiding the Department of Psychiatry toward continued excellence.
New evidence challenges understanding of Parkinson's disease. Read more
Pourquoi certains agissent-ils en héros et d’autres non? Lire ici
Brain discovery opens door to earlier detection of metabolic syndrome in women. Lire ici
Le Canada devrait-il interdire les réseaux sociaux aux jeunes comme le fait l’Australie? Lire ici
Australie : interdire les réseaux sociaux aux moins de 16 ans, une solution? Écoutez ici
Brain discovery opens door to earlier detection of metabolic syndrome in women. Lire ici
Le Canada devrait-il interdire les réseaux sociaux aux jeunes comme le fait l’Australie? Lire ici
Clarivate has released its 2025 Highly Cited Researchers™ (HCRs) list, recognizing scientists whose publications rank among the top 1% most cited worldwide in their fields. This year, 24 McGill researchers, including 11 members of the Faculty of Medicine and Health Sciences (FMHS), earned this distinction. Congratulations to Dr. Turecki for being among this select group of globally influential researchers!
Avancées en psychiatrie: «Ce n’est pas difficile de traiter la dépression». Écoutez ici
Dr. Bruno Giros has been appointed to the Neuropsychopharmacology Committee of the International Union of Basic and Clinical Pharmacology (IUPHAR) as the representative of the Canadian Society for Pharmacology and Therapeutics (CSPT). This appointment recognizes his outstanding expertise in neuropharmacology and his commitment to advancing research on neuropsychiatric and neurodegenerative disorders.
